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DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING
May 18, 2020

Executive Summary
NM Highlights: NM COVID safety guidelines. NM case count. Navajo Nation case count. Gadsden school
district kitchens closures. ABQ non-COVID patient treatment delay. NM factory shutdowns.
US Highlights: Moderna Inc. vaccine shows promise. US cases exceed 1.5 million. US states reopen. NY slowly
reopening. Michigan vaccines decrease. CDC antibody study.
International Highlights: WHO independent review.
Economics, Workforce, Supply Chain, PPE Highlights: Maxillofacial surgeries down. PPE skin damage.
Epidemiology Highlights: Infections may overwhelm ICE facilities. High estimated US infections. LA antibody
testing results. Super-spreader in church. Hospital staff antibody response. No effect of climate.
Healthcare Policy Recommendations: Pairing assistance to alleviate health system failure. Exercise
recommendations. CDC funeral guidance.
Practice Guidelines: Emergency Dept. Patient isolation triage tool. Gynecology ward rearrangement.
Guidelines for nuclear cardiology labs.
Testing: PCR without RNA extraction. Comparison of PCR kits. Comparison of IgG assays. Sequencing for
screening.
Drugs, Vaccines, Therapies, Clinical Trials: Subcutaneous tocilizumab. Five new antivirals. 28 new COVID-19
trials.
Other Science: PTSD in healthcare workers. Antibody neutralizes virus. Good pregnancy outcomes. Males at
risk. CDC: hospitalization and mortality rates. News makes people sad. African green monkey model. Air is
cleaner.
All of our past briefings are maintained in a UNM library repository here.
Our continuously curated practice guidelines in the context of COVID-19 can be found here.
Our continuously curated therapeutic evidence is maintained here.
You may submit content for future briefings here.

NM Highlights


New Mexico COVID-safe practices for individuals and employers
The document, released by the government on 5/15, details how to live in a COVID-positive New Mexico and what the public
and private sectors can do to stay safe. It specifically notes a social contract where the primary takeaways are: be

responsible, be patient, be prepared, be educated, and stay home. Safe practices that are required or are deemed best
practice are specified for employers in service, manufacturing, religious, agriculture, construction, automotive and medical
industries.



NM reports 5 more COVID-19 deaths and 165 additional cases on May 18
As of today (5/18), the total positive cases and total deaths in the state are 6,096 and 270, respectively. The state has
performed 137,620 tests, there are 213 individuals currently hospitalized for COVID-19, and 1,796 COVID-19 cases have
recovered. NMDOH portal featuring epidemiologic breakdown of cases.



COVID-19 cases rise to 4,002 on Navajo Nation with 140 reported deaths
The total number of confirmed COVID-19 cases for the Navajo Nation has reached 4,002 with 140 deaths. Officials reported
that over 24,886 COVID-19 tests have been administered so far and the Navajo Nation is now testing at large-scale.



Four Gadsden school district kitchens close over COVID-19 exposure
North Valley (San Miguel), Yucca Heights (Chaparral), Desert View (Sunland Park) and Vado elementary kitchens will close
indefinitely after 20 employees between the four schools self-reported possible exposure or symptoms.



Non-COVID patients in Albuquerque delaying treatment for serious conditions
The risk of contracting coronavirus and stay-at-home orders are two possible reasons people are avoiding emergency rooms
in ABQ. Nationwide, 80% of adults said they are concerned about getting COVID-19 from another person in an emergency
room and 29% said they have delayed or avoided medical treatment, according to a late April survey by the American College
of Emergency Physicians and Morning Consult.



New Mexico exporters hurt by factory shutdowns due to COVID-19 pandemic
Due to the coronavirus outbreak, many companies at the Santa Teresa industrial parks have had to cut hours, announce
furloughs or layoffs, or temporarily shut down their plants. Many companies at Santa Teresa’s industrial plants are not
affected by stay-at-home orders as they are considered essential, but disruptions in global supply chains from Asia to the U.S.
to Mexico and decline in demand from U.S. manufacturers are hurting them.

US Highlights


Dose-dependent vaccine showed positive protective antibody response in 8 patients
Moderna's COVID-19 vaccine shows promise. Phase 2 will begin with optimizing dosage and longevity of antibody protection.
Moderna expects to start phase 3 in July. So far, the most notable side effects reported are “flu-like” symptoms from three
participants. It is predicted that a safe and effective vaccine could take 12-18 months to develop.



U.S. cases exceed 1.5 million with rise in some southern states
Most states reported a drop in new cases for the week, with only 13 states seeing a rise in infections compared to the
previous week. Tennessee had the biggest weekly increase with 33%. Louisiana’s new cases rose 25%, and Texas reported
22% more cases. Michigan saw new cases rise 18% after five weeks of initial decline. Nationally, new cases of COVID-19 are
down 8% in the last week. CDC recommends a 14-day decrease in daily cases before easing on social distancing.



States press on with re-openings
Almost all 50 states are in some stage of reopening this week, but only 14 states have met the recommendation for a 14-day
decline in cases before lifting measures. Some southern states and protesters are pushing to reopen more quickly.



New York continues to slowly reopen, including Niagara Falls
Niagara Falls to start reopening after meeting criteria for managing hospitalizations and tracing viral spread. Three more
counties will reopen on Tuesday, starting with construction and manufacturing and some retail operations. The NY governor
encouraged sports teams to resume play and televise games without fans present.



Vaccine coverage in children decreased in Michigan during pandemic
Data from the Michigan Care Improvement Registry show vaccine coverage has declined among most children ≤2 in May.
The only vaccine coverage which did not decline was birth-dose hepatitis B coverage, which is typically administered in a

hospital setting. CDC advises that vaccines are essential should continue while stay-at-home orders are in place.



U.S. CDC plans COVID-19 antibody study in 25 metropolitan areas
The CDC plans a nationwide study of up to 325,000 people to track how COVID-19 is spreading across the country. The study
to launch in June and will test samples from blood donors in 25 metropolitan areas for 12 months. A precursor study is
currently surveying samples from New York, Seattle, San Francisco, Los Angeles, Boston and Minneapolis. Results will be
published on a rolling basis.

International Highlights


WHO to launch independent review of global coronavirus response
The World Health Organization announced that an independent review of the global coronavirus response will begin soon.
The organization also received $2 billion in pledged support from China. This amount compensates for President Trump's
freezing of U.S. payments to the WHO worth about $400 million/year.

Economics, Workforce, Supply Chain, PPE Highlights


Impact of COVID-19 on maxillofacial surgery practice: a worldwide survey
In 82% of the responding centers that had remained open, the maxillofacial sub-specialties had been reorganized.
Traumatology was reported as the service that was most maintained, with 13.5% closing this subspecialty. Oral surgery,
practiced in 90.4% of centers, decreased activity to 34.6%. Oral surgery remained one of the three most active subspecialties
together with traumatology (66.7%) and head and neck tumor surgery (37.2%). The greatest reduction in activity occurred in
both orthognathic surgery and temporomandibular joint (TMJ) surgery.



Impact of PPE of skin care needs: letter
This letter from dermatologists in Italy highlights their experiences with damage to skin from long-term PPE use. Authors
mention that damaged skin is more susceptible to infection (dermatitis and other inflammatory symptoms). Authors
prescribed application of moisturizers on intact skin and topical antibiotic ointment on infected skin. Persistent contact
dermatitis called for topical steroid use. Sustained dermatosis, worsening of preexisting diseases such as psoriasis or atopic
dermatitis or allergic reactions might require more complex assessment and management, including the temporary removal
from work for health care personnel.

Epidemiology Highlights


COVID-19 infections may overwhelm US ICE detention facilities and ICU beds
A computational model estimated the rate of COVID-19 transmission within 111 Immigration and Customs Enforcement (ICE)
detention facilities and then examined impacts on regional hospital ICU capacity. Models considered three scenarios of
transmission (optimistic, moderate, pessimistic) over 30-, 60-, and 90-day time horizons across a range of facility sizes. 72%
of individuals are expected to be infected by day 90 under the optimistic scenario (R0 = 2.5), while nearly 100% of individuals
are expected to be infected by day 90 under a more pessimistic (R0 = 7) scenario. In the most optimistic scenario, outbreaks
among a minimum of 65 ICE facilities (59%) would overwhelm ICU beds within a 10-mile radius and outbreaks among a
minimum of 8 ICE facilities (7%) would overwhelm local ICU beds within a 50-mile radius over a 90-day period, provided
every ICU bed was made available for sick detainees. A recent press article shows COVID-19 cases among ICE detainees rose
steadily from April to mid-May, reaching 943 on May 13, 2020. The agency said 1,788 detainees had been tested out of a
reported 29,675 detainees.



Estimated infections much higher than actual number of confirmed cases inthe U.S.
MedRxiv preprint: An analysis estimated the number of COVID-19 infections was 3 to 20 times higher than the number of
confirmed cases. 86% of this difference was due to incomplete testing, while 14% was due to imperfect test accuracy.
Estimates of COVID-19 infections that transparently account for testing practices and diagnostic accuracy reveal that the
pandemic is larger than confirmed case counts suggest.



SARS-CoV-2 antibody: 4.7% positive in LA random sample
JAMA: A random sample of LA residents was tested for COVID-19 antibodies, April 10-11 (N=865). The fraction that tested
positive varied by race/ethnicity, sex, and income. After adjusting for test sensitivity and specificity, the weighted prevalence
of SARS-CoV-2 antibodies was 4.65%. Fatality rates based on confirmed cases may be higher than those based on infections.



COVID-19 positive person exposes 180 people at church service
A person attended a California religious service on Mother's Day and was diagnosed for COVID-19 two days later exposed 180
other people. People who attended the service have been notified about their exposure and received instructions from
health officials to self-quarantine. Officials are working to get testing for everyone who was in attendance.



Symptoms and immunoglobulin development in exposed hospital staff
Symptoms and antibody responses in 201 healthcare workers were analyzed following a COVID-19 outbreak at a German
children’s and women’s hospital. 31 healthcare workers were confirmed as cases by RT-PCR SARS-CoV-2 tests. Anosmia and
coughing were more frequently reported in patients with a positive test. Approximately 80% of cases developed some
specific antibody response (IgG or IgA) about 3 weeks after onset of symptoms. However no significant difference was found
between cases with or without antibody responses. The results suggest that COVID-19 infection may not necessarily lead to
immunity as approximately 20% of patients did not mount a measurable immune response after symptom onset.



Summer weather will not substantially limit pandemic growth
Science: A study used a climate-dependent epidemic model to simulate the SARS-CoV-2 pandemic probing different scenarios
based on known coronavirus biology. The results show that while variations in weather may be important for endemic
infections, during the pandemic stage of an emerging pathogen, the climate drives only modest changes to pandemic size.

Healthcare Policy Recommendations


China adopts nationwide "pairing assistance" to alleviate breakdown of healthcare system
Pairing assistance allows at least one province to provide medical personnel to cities with high COVID burden. Specifically, 29
provinces will be “paired” with cities in Hubei. This attempts to alleviate pressure in severe areas.



Exercise recommendations include short active breaks throughout the day
This article summarizes recommendations from major healthcare institutions: ACSM, AHA, COLEF, SEC/FEC, WHO, and
SEMED/CGCOM. The general agreement is to take short, active breaks several times a day to avoid long, sedentary periods.
Examples include walks around the house, short online exercise videos, and stretching.



CDC funeral guidance
CDC recommends modified funeral arrangements with a small number of immediate family and friends at in-person funerals.
Face coverings and 6 feet distancing should be enforced. Funeral rituals should be modified to avoid physical contact with
the deceased.

Practice Guidelines


Emergency department triage tool for identifying patients requiring isolation
MedRxiv preprint: A novel system of patients triaging was implemented at the University College London Hospital. All
admitted patients were allocated to one of 4 categories: (A) - low likelihood of COVID-19 but significant comorbidities – they
were given the highest priority for single-occupancy rooms; (B and C) - high probability of COVID-19, with category B having
significant comorbidities. Category B patients were second priority for single-occupancy rooms. When such rooms were
unavailable these patients were cohorted in reduced occupancy multi-bedded bays on wards designated for suspected
COVID-19 patients; (C) -minimal comorbidities –cohorted in the same reduced occupancy multi-bedded bays with other
category C or B patients; (D)- low probability of COVID-19 and no significant comorbidities - cohorted together on the same
ward as suspected COVID-19 patients.



European Hernia Society guidelines for hernia management during COVID-19
The European Hernia Society published recommendations on abdominal wall surgery including managing emergency cases,
elective surgery, and triage measures. Some of the principles of abdominal wall surgery were clarified a result of recent
criticism (mesh, minimally invasive surgery) and adaptation of technique (midline restoration) to minimize raising intraabdominal pressure. In the absence of suspected strangulated tissue in the hernia, the use of taxis (manual reduction of the
incarcerated hernia) under sedation/analgesia followed by observation may allow surgery to be safely delayed for a number
of weeks. There is no evidence for contraindication of the laparoscopic approach. There is little-to-no evidence of infection
via blood transmission or as a consequence of a pneumoperitoneum per se from patient to healthcare worker. The
desufflation of any gas from the pneumoperitoneum through a virus filter is recommended. Trocar wounds should be kept at
minimum length to avoid air leaks around the port. In the case of open-access trocars, the use of ports with retention balloon
should be considered to minimize inadvertent removal of the port. COVID-19 is found in the stool of a proportion of patients,
thus, in any surgery in which the bowel is opened, regardless whether laparo/endoscopic or open, care should be taken
because of the presumed risk of virus exposure from the intestinal content.



Australian and New Zealand guidelines on management of hematologic malignancies
A consensus between authors from Australia and New Zealand recommends that patients should be informed of their
vulnerability to COVID‐19. Use telemedicine and non‐hospital pathology services, change i.v. preparations to subcutaneous,
and use direct‐to‐home delivery of oral medications. The informed consent process for chemotherapy should include
documenting a discussion about the risks of COVID‐19 and strategies to avoid infection, as well as the potential risks of
reduced hospital capacity to deliver on‐time chemotherapy and routine supportive care. If infected with COVID‐19 during
chemotherapy, the decision to continue or re‐initiate chemotherapy needs to be made on a case‐by‐case basis. Specific
recommendations are given on managing each individual type of malignancy.



Management of gynecology patients during pandemic: Chinese recommendations
The experts from the Chinese Obstetricians and Gynecologists Association describe basic infection precaution principles, an
epidemiological screening tool, prioritization of surgical procedures, and operating room requirements. Using these
principles, authors then reviewed management of gynecologic patients during the pandemic in the outpatient and operative
and non-operative inpatient settings, as well as in clinical trials.



New strategy for gynecological ward rearrangement and zoning management
Wuhan authors share their strategy to effectively minimize nosocomial infections in gynecology department. The strategy
included the following measures: screening for COVID-19 before inpatient treatment; education; attention to the mental
health of inpatients, their families, and medical personnel; patient redistribution; treatment modifications, use of PPE.



Guidance for nuclear cardiology laboratories
American Society of Nuclear Cardiology (ASNC) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) describe
steps for protection of healthcare personnel, inpatients, outpatients, and ED patients.

Testing


Comparison of SARS-CoV-2 detection by direct PCR with and without RNA extraction
Journal of Clinical Virology: This study compares the direct rRT-PCR method (without RNA extraction) using SeeGene
AllplexTM 2019-nCoV rRT-PCR with the RealStar SARS-CoV-2 rRT-PCR kit (Altona Diagnostics). Type of swab specimen storage
determines type of PCR: If samples are collected in UTM or molecular water and screened rapidly, PCR without RNA
extraction can be used. If samples are in saline water or Hanks medium, then PCR with RNA extraction is used. They found
that SeeGene and Altona kits provide similar efficiency.



Comparison of seven commercial RT-PCR diagnostic kits for COVID-19
Journal of Clinical Virology: Many commercial kits have not been independently assessed. This study compares basic
analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI,
CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). Researchers ran a panel (n=13) of positive samples
for clinical sensitivity. They also used non-corona respiratory infections (n=6) to evaluate specificity. Researchers concluded

that all commercially available RT-PCR kits included in this study can be used for routine diagnostics of symptomatic COVID19 patients.



Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
Journal of Clinical Virology: The authors compared four new commercially available assays using 75 sera from patients that
tested positive or negative for SARS-CoV-2. The assays are the anti SARS-CoV-2 ELISA (IgG), the EDI New Coronavirus COVID19 IgG ELISA, the recomWell SARS-CoV-2 IgG ELISA, and the SARS-CoV-2 Virachip IgG. The sensitivities for the assays ranged
from 77.3% to 100% while the specificities ranged from 88.7% to 100%. The EDI assay had the highest sensitivity, while the
Virachip assay had the highest specificity. The authors conclude that the four assays showed sufficient specificity and
sensitivity for identifying individuals with past Covid-19 infection, but combination of two different assays may increase these
two measures.



REMBRANDT: A high-throughput barcoded sequencing approach for screening
BioRxiv preprint: REcombinase Mediated BaRcoding and AmplificatioN Diagnostic Tool (REMBRANDT), a high-throughput
Next Generation Sequencing-based approach for the simultaneous screening of over 100,000 samples per day. The protocol
includes direct two-barcoded amplification of SARS-CoV-2 and control amplicons using an isothermal reaction, and the
downstream library preparation for Illumina sequencing and bioinformatics analysis.

Drugs, Vaccines, Therapies, Clinical Trials


Use of subcutaneous tocilizumab in patients with Covid-19 pneumonia
In a letter to the editor in Journal of Medical Virology, Italian authors discuss three cases of patients with Covid-19
pneumonia not requiring mechanical ventilation who were treated with a single dose of Tocilizumab administrated, for the
first time, subcutaneously. The authors observed favorable clinical outcomes (e.g. decreased fever, weaning of oxygen
therapy) and improvements in inflammatory biomarkers, such as IL-6.



Five antivirals comparable to remdesivir in vitro
BioRxiv preprint: Swiss scientists discuss the identification of 5 antivirals which potently inhibited SARS-CoV-2 replication and
displayed equal or even higher antiviral efficacy to remdesivir. Compounds from the antimicrobial "Pandemic Response Box"
library were screened for inhibiting properties against SARS-CoV-2. The five candidate compounds identified (chloroquine,
NN-DNJ, PDNJ0803, URMC-099-C, and Retro-2.1) have previously also been demonstrated to inhibit the replication of other
204 RNA-viruses such as filoviruses, flaviviruses and picornaviruses. These five compounds should be further investigated for
their mode of action, safety and efficacy.



28 New COVID-19 Trials registered today at clinicaltrials.gov
Treatment trials: [convalescent plasma, anti-CD14, dipyridamole, colchicine with phenolic monoterpenes, cold laser therapy,
hyperimmune convalescent plasma, hydroxychloroquine and ivermectin, CytoSorb therapy, hydroxychloroquine sulfate and
azithromycin, EIDD-2801, nitazoxanide and ribavirin and ivermectin]. At time of writing, a total of 1474 were active, 80
completed, and 3 posted results.

Other Science


Post-traumatic stress symptoms of healthcare workers
The study evaluated healthcare workers (HCWs) (n=337) on sleep quality after one month of stressful events using the
Pittsburgh Sleep Quality Index (PSQI) and the DSM-5 PTSD checklist. PTSS was 3.8% in HCWs. Female HCWs were more
vulnerable to PTSS. HCWs with higher exposure level also significantly rated more hyper-arousal symptoms. There was a
significant difference of sleep quality between participants with and without PTSS (p<0.001) and among different groups with
various contact frequency (p=0.026). Researchers conclude that targeted interventions on sleep contribute to the mental
recovery of HCWs. (Article behind Wiley paywall)



Neutralization of SARS-CoV-2 using SARS-CoV antibody
Nature accelerated article: The researchers describe multiple monoclonal antibodies targeting SARS-CoV-2 S using memory B

cells from an individual infected with SARS-CoV in 2003. The S309 antibody neutralizes SARS-CoV-2 and SARS-CoV
pseudoviruses by engaging the S receptor-binding domain. A combination of S309 with other antibodies further enhanced
SARS-CoV-2 neutralization, potentially limiting the emergence of neutralization-escape mutants.



Pregnancy outcomes overall good: systematic review
MedRxiv preprint: The review of 164 pregnancies complicated by maternal SARS-CoV-2 infection across 20 studies. 84.5%
delivered via Cesarean section, with a 23.9% rate of maternal gestational complications, 20.3% rate of preterm delivery, and
a 2.3% rate of stillbirth delivery. Relative to known viral infections, the authors consider the prognosis for pregnant women
with SARS-CoV-2 to be good, even in the absence of specific antiviral treatment.



Male sex consistent risk factor for severity: systematic review & meta-analysis
MedRxiv preprint: The meta-analysis of 31 studies (n=7,556) showed males constitute a significantly higher proportion of
those who had adverse clinical outcomes and died. Males accounted for 53% of all cases, males accounted for an increasing
proportion of severe cases (56%), critically ill cases (71%), and mortalities (69%) compared to their counterpart. The authors
suggest early identification and medical care for males with confirmed cases may substantially change the course of clinical
prognosis.



CDC reports decline of percent of positive tests and COVID-19 associated mortality
Nationally, visits to outpatient providers and emergency departments for illnesses with symptoms consistent with COVID-19
continued to decline. The overall cumulative COVID-19 associated hospitalization rate is 60.5 per 100,000, with the highest
rates in people 65 years of age and older (192.4 per 100,000) and 50-64 years (94.4 per 100,000). The percentage of deaths
attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 17.8% during week 18 to 12.8% during the week of
May 2-9.



Exposure to COVID-19 mainstream news associated with depressive symptoms
This cross-sectional study (n=501) considers the associations between exposure to COVID-19 news, risk perceptions, and
depressive symptoms. News exposure and depression was screened using a questionnaire. After controlling for
sociodemographic and socio-economic factors, news exposure was positively associated with depressive symptoms
(beta=.11, 95% CI). The authors offer recommendations for media–health partnership, practice, and research. (Article behind
Wiley paywall)



African green monkey as an animal model for SARS-CoV-2
BioRxiv preprint: African green monkeys support a high level of SARS-CoV-2 replication and develop pronounced respiratory
disease that may be more substantial than reported for other species. The virus was detected in mucosal samples of all
animals including feces of several animals as late as 15 days after virus exposure. Virus replication and respiratory disease can
be produced in African green monkeys using a low dose.



Improved air quality following COVID-19 isolation
Particulate matters (PM2.5) represents air quality of a location. In this short communication, the authors present analysis of
PM2.5 of major cities (New York, Los Angeles, Zaragoza, Rome, Dubai, Delhi, Mumbai, Beijing and Shanghai) around the
world that have suffered severely with the pandemic. The analysis shows decline in PM2.5 concentration due to lockdown,
mainly due to less traffic and travel.

Contributing team members: Christophe G. Lambert, Shawn Stoicu, Ingrid Hendrix, Lori Sloane, Mari Anixter,
Anastasiya Nestsiarovich, Praveen Kumar, Nicolas Lauve, Fiona Nguyen, Ryen Ormesher, Melissa Cossé, Susie
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